Abstract
The advent of ctDNA has the potential to be a game changer in some cancers, but limited data is available in oesophago-gastric cancers (OGC). The prognostic value of ctDNA and the potential for false positive results due to clonal haematopoiesis of indeterminate potential (CHIP) was recently reported in operable OGC.
Cite
CITATION STYLE
APA
De Paula, B., & C Smyth, E. (2021, October 12). Personalising care in oesophageal cancer care with liquid biopsy. British Journal of Cancer. Springer Nature. https://doi.org/10.1038/s41416-021-01370-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free